Medicaid expansion and treatment for opioid use disorders in Oregon: an interrupted time-series analysis

被引:18
作者
McCarty, Dennis [1 ]
Gu, Yifan [2 ]
McIlveen, John W. [3 ]
Lind, Bonnie K. [2 ]
机构
[1] Oregon Hlth & Sci Univ, OHSU PSU Sch Publ Hlth, 3181 Sw Sam Jackson Pk Rd, Portland, OR 97239 USA
[2] Oregon Hlth & Sci Univ, Ctr Hlth Syst Effectiveness, 3181 Sw Sam Jackson Pk Rd, Portland, OR 97239 USA
[3] State Opioid Treatment Author, Oregon Hlth Author, 500 Summer St, Salem, OR 97301 USA
基金
美国国家卫生研究院;
关键词
Opioid use disorder; Opioid agonist therapy; Opioid antagonist therapy; Medicaid expansion; Psychosocial services for opioid use disorder; Medication for opioid use disorder; COVERAGE; IMPACT;
D O I
10.1186/s13722-019-0160-6
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Background The study examined the association of the Affordable Care Act's 2014 Medicaid expansion on the use of psychosocial services and pharmacotherapies for opioid use disorders among Oregon Medicaid recipients. Methods Logistic regression analysis examined utilization of care before (January 1, 2010-December 31, 2013) and after Medicaid expansion in Oregon (January 1, 2014-December 31, 2016). Results Adult membership in the Oregon Health Plan (Medicaid) increased 180% following Medicaid expansion (2013 = 172,539; 2014 = 482,081) and the number with a diagnosis of OUD nearly doubled (2013 = 6808; 2014 = 13,418). More individuals received psychosocial services (2013 = 4714; 2014 = 8781) and medications (2013 = 3464; 2014 = 6093) for opioid use disorder. The percent of patients receiving psychosocial services (69% to 65%) and the percent of individuals receiving pharmacotherapy (57% to 45%) declined primarily because of a decline in the proportion receiving care in an opioid treatment program (2013 = 41%; 2014 = 33%). Odds of accessing any psychosocial service increased by 8% per year from 2010 to 2013 (AOR = 1.08; 95% CI 1.06-1.11) with an 18% immediate decline associated with Medicaid expansion in 2014 (AOR = 0.82; 95% CI 0.76-0.87). Following Medicaid expansion, the odds of accessing psychosocial services increased 8% per year (2014 through 2016) (AOR = 1.08; 95% CI 1.06-1.11). Use of medications for opioid use disorder found no change in the odds of use in the years prior to Medicaid expansion, an immediate 36% (AOR = 0.64; 95% CI 0.60-0.68) decline in 2014, and a 13% increase per year in 2015 and 2016 (AOR = 1.13; 95% CI 1.09-1.16). Conclusion The number of Medicaid recipients with an opioid use disorder who received psychosocial and pharmacological services increased substantially following Oregon's Medicaid expansion in 2014. There was a decline, however, in the proportion of individuals with an opioid use disorder receiving care in opioid treatment programs.
引用
收藏
页数:8
相关论文
共 6 条
  • [1] [Anonymous], DIAGN STAT MAN MENT
  • [2] Trends in insurance coverage and treatment among persons with opioid use disorders following the Affordable Care Act
    Feder, Kenneth A.
    Mojtabai, Ramin
    Krawczyk, Noa
    Young, Andrea S.
    Kealhofer, Marc
    Tormohlen, Kayla N.
    Crum, Rosa M.
    [J]. DRUG AND ALCOHOL DEPENDENCE, 2017, 179 : 271 - 274
  • [3] Impact Of Medicaid Expansion On Coverage And Treatment Of Low-Income Adults With Substance Use Disorders
    Olfson, Mark
    Wall, Melanie
    Barry, Colleen L.
    Mauro, Christine
    Mojtabai, Ramin
    [J]. HEALTH AFFAIRS, 2018, 37 (08) : 1208 - 1215
  • [4] Oregon Dental Association, 2019, OR DENT IMM ADM
  • [5] Penfold RB, 2013, ACAD PEDIATR, V13, pS38, DOI 10.1016/j.acap.2013.08.002
  • [6] Impact of Medicaid Expansion on Medicaid-covered Utilization of Buprenorphine for Opioid Use Disorder Treatment
    Wen, Hefei
    Hockenberry, Jason M.
    Borders, Tyrone F.
    Druss, Benjamin G.
    [J]. MEDICAL CARE, 2017, 55 (04) : 336 - 341